Prime Capital Investment Advisors LLC lifted its holdings in Bristol-Myers Squibb ( NYSE:BMY – Get Rating ) by 36.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,251 shares of the biopharmaceutical company's stock after purchasing an additional 4,335 shares during the period. Prime Capital Investment Advisors LLC's holdings in Bristol-Myers Squibb were worth $1,169,000 at the end of the most recent reporting period. Other institutional investors have also recently made changes to their positions in the company.

https://www.dailypolitical.com/2023/05/09/prime-capital-investment-advisors-llc-increases-stock-position-in-bristol-myers-squibb-nysebmy.html

#dailypolitical